Agilent Technologies (NYSE:A) Downgraded by Wolfe Research

Agilent Technologies (NYSE:A) was downgraded by analysts at Wolfe Research from an “outperform” rating to a “peer perform” rating in a research note issued to investors on Thursday, Briefing.com reports.

Several other equities analysts also recently issued reports on A. UBS Group decreased their price objective on shares of Agilent Technologies from $155.00 to $141.00 and set a “neutral” rating on the stock in a report on Thursday, May 30th. Robert W. Baird decreased their price objective on shares of Agilent Technologies from $147.00 to $136.00 and set an “outperform” rating on the stock in a report on Thursday, May 30th. Stifel Nicolaus decreased their price target on shares of Agilent Technologies from $163.00 to $151.00 and set a “buy” rating on the stock in a research note on Thursday, May 30th. Evercore ISI decreased their price target on shares of Agilent Technologies from $145.00 to $126.00 and set an “in-line” rating on the stock in a research note on Thursday, May 30th. Finally, Bank of America raised their price target on shares of Agilent Technologies from $134.00 to $140.00 and gave the stock a “neutral” rating in a research note on Tuesday. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and nine have assigned a buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $136.88.

Agilent Technologies Stock Down 1.2 %

A stock opened at $133.04 on Thursday. The firm has a market cap of $38.82 billion, a PE ratio of 31.45, a P/E/G ratio of 4.57 and a beta of 1.07. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.64 and a current ratio of 2.15. The firm’s fifty day moving average is $139.69 and its 200 day moving average is $138.49. Agilent Technologies has a one year low of $96.80 and a one year high of $155.35.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, May 29th. The medical research company reported $1.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.19 by $0.03. The business had revenue of $1.57 billion for the quarter, compared to the consensus estimate of $1.58 billion. Agilent Technologies had a net margin of 18.84% and a return on equity of 26.25%. The company’s revenue was down 8.4% compared to the same quarter last year. During the same period last year, the firm posted $1.27 earnings per share. On average, research analysts forecast that Agilent Technologies will post 5.25 EPS for the current year.

Insider Buying and Selling

In other Agilent Technologies news, SVP Dominique Grau sold 15,000 shares of Agilent Technologies stock in a transaction dated Monday, June 10th. The shares were sold at an average price of $133.28, for a total transaction of $1,999,200.00. Following the completion of the sale, the senior vice president now directly owns 49,486 shares in the company, valued at $6,595,494.08. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,958 shares of Agilent Technologies stock in a transaction dated Monday, June 3rd. The shares were sold at an average price of $130.00, for a total transaction of $254,540.00. Following the completion of the sale, the chief executive officer now directly owns 25,185 shares in the company, valued at $3,274,050. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, SVP Dominique Grau sold 15,000 shares of Agilent Technologies stock in a transaction dated Monday, June 10th. The shares were sold at an average price of $133.28, for a total transaction of $1,999,200.00. Following the sale, the senior vice president now owns 49,486 shares of the company’s stock, valued at $6,595,494.08. The disclosure for this sale can be found here.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the business. Livelsberger Financial Advisory acquired a new position in shares of Agilent Technologies in the fourth quarter valued at approximately $26,000. MV Capital Management Inc. grew its holdings in shares of Agilent Technologies by 120.7% in the fourth quarter. MV Capital Management Inc. now owns 192 shares of the medical research company’s stock valued at $27,000 after purchasing an additional 105 shares in the last quarter. VisionPoint Advisory Group LLC acquired a new position in shares of Agilent Technologies in the fourth quarter valued at approximately $29,000. Rise Advisors LLC grew its holdings in shares of Agilent Technologies by 527.8% in the first quarter. Rise Advisors LLC now owns 226 shares of the medical research company’s stock valued at $33,000 after purchasing an additional 190 shares in the last quarter. Finally, YHB Investment Advisors Inc. purchased a new position in Agilent Technologies in the first quarter worth approximately $34,000.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.